1992
DOI: 10.1111/j.1365-4362.1992.tb03250.x
|View full text |Cite
|
Sign up to set email alerts
|

DETECTION OF AUTOIMMUNITY PARAMETERS IN THE ACQUIRED IMMUNODEFICIENCY SYNDROME (aids)

Abstract: We have examined various autoimmunity parameters in AIDS with special emphasis on the expression of pemphigus and bullous pemphigoid antibodies. Sera from healthy seropositive individuals without syphilis (CS-, n = 17), seropositive individuals with syphilis (cs+, n = 11), and patients with AIDS (n = 6) were studied and compared with normal controls (n = 30); autoimmunity parameters related to dermatology were evaluated. Indirect immunofluorescence (IIF) for pemphigus and pemphigoid antibodies, antinuclear ant… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
3
0
1

Year Published

1995
1995
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(4 citation statements)
references
References 15 publications
0
3
0
1
Order By: Relevance
“…Basically, autoantibodies that have been identified in the sera of HIV-1-infected patients can be divided into three distinct but overlapping groups of autoantigens. These include autoantibodies against cell surface molecules such as CD4, MHC class I and II, TCR, and Fas, to name a few; [13][14][15][16][17] organ-specific autoantibodies such as antiplatelet antibodies, anti-cardiac myosin antibodies, anti-smooth musclespecific antibodies, and anti-erythroid cell-specific antibodies; [18][19][20] and, lastly, nonorgan-specific antibodies such as antinuclear antibodies, antihistone antibodies, anti-double-stranded DNA antibodies, [21][22][23][24] and antiphospholipid antibodies. 25 Each of these categories of antibodies has been characterized to contribute to the pathogenesis of human HIV-1 infection.…”
Section: Targets Of Autoimmune Responsesmentioning
confidence: 99%
“…Basically, autoantibodies that have been identified in the sera of HIV-1-infected patients can be divided into three distinct but overlapping groups of autoantigens. These include autoantibodies against cell surface molecules such as CD4, MHC class I and II, TCR, and Fas, to name a few; [13][14][15][16][17] organ-specific autoantibodies such as antiplatelet antibodies, anti-cardiac myosin antibodies, anti-smooth musclespecific antibodies, and anti-erythroid cell-specific antibodies; [18][19][20] and, lastly, nonorgan-specific antibodies such as antinuclear antibodies, antihistone antibodies, anti-double-stranded DNA antibodies, [21][22][23][24] and antiphospholipid antibodies. 25 Each of these categories of antibodies has been characterized to contribute to the pathogenesis of human HIV-1 infection.…”
Section: Targets Of Autoimmune Responsesmentioning
confidence: 99%
“…Neben Arthritiden kommen auch kollagenoseähnliche Verläufe [28] wie das dem Sjögren-Syndrom ähnliche,diffus infiltrierende Lymphozytosesyndrom (DILS) oder lupusähnliche Syndrome mit ANA (40-95% der AIDS-Patienten) und positiven ENA im Immunoblot (SM, U1-RNP, SSA-Antikörper [33]) vor.…”
Section: Autoimmunphänomene Bei Hiv-infektionunclassified
“…Most antibodies belong to the immunoglobulin (Ig)G class and bind to the hemidesmosomal proteins BP180 and BP230 3 . Occurrence of BP in patients infected with human immunodeficiency virus (HIV) has rarely been reported and it is possible to find autoantibodies of BP in HIV carrier blood, even without evident clinical manifestation 1,4,5 . Topical superpotent corticosteroids are the first-line treatment, along with doxycycline or oral prednisolone in extensive severe cases, usually with good response 3 .…”
Section: Introductionmentioning
confidence: 99%